High SLC1A5 expression has been correlated with poor survival in various types of cancer, including hepatocellular carcinoma [37], lung cancer [13], breast cancer [38], colon cancer [39] and head and neck squamous cancer [40]. Here, SLC1A5 is linked to breast carcinoma.